Will Brexit spring a leak in AstraZeneca’s talent pool?
As drug pricing policies dominate pharmaceutical headlines, the threat of economic nationalism looms even larger over AstraZeneca’s R&D pipeline.
img:is([sizes=auto i],[sizes^="auto," i]){contain-intrinsic-size:3000px 1500px} /*# sourceURL=wp-img-auto-sizes-contain-inline-css */
As drug pricing policies dominate pharmaceutical headlines, the threat of economic nationalism looms even larger over AstraZeneca’s R&D pipeline.
Can wearables and electronic data capture (EDC) technologies improve clinical trials and accelerate new drug approval?